UK markets close in 6 hours 28 minutes

Celldex Therapeutics, Inc. (CLDX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
31.91+1.79 (+5.94%)
At close: 04:00PM EST
32.50 +0.59 (+1.85%)
After hours: 05:08PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
8,102
7,418
3,573
9,538
Operating expenses
Research development
49,058
42,534
42,672
66,449
Selling general and administrative
17,870
14,456
15,426
19,269
Total operating expenses
66,928
56,990
58,098
85,942
Operating income or loss
-58,826
-49,572
-54,525
-76,404
Total other income/expenses net
-14,603
-11,375
3,647
-75,545
Income before tax
-73,429
-60,947
-50,878
-151,949
Income tax expense
-1,166
-1,167
0
-765
Income from continuing operations
-72,263
-59,780
-50,878
-151,184
Net income
-72,263
-59,780
-50,878
-151,184
Net income available to common shareholders
-72,263
-59,780
-50,878
-151,184
Basic EPS
-
-2.02
-3.51
-14.48
Diluted EPS
-
-2.02
-3.51
-14.48
Basic average shares
-
29,640
14,507
10,442
Diluted average shares
-
29,640
14,507
10,442
EBITDA
-
-45,643
-49,667
-72,603